Nanotransfer logo — Developing the next generation delivery system for gene ther...

Nanotransfer

Developing the next generation delivery system for gene therapies

Founded 2021 Argentina Cordoba, Argentina 6 employees Pre-Seed Total: $200.00K Biotechnology, Health Care

General Information

Company Name Nanotransfer
Founded Year 2021
Location Argentina Cordoba, Argentina
Employees 6
Industries Biotechnology, Health Care
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Nanotransfer. To contact Nanotransfer, visit nanotransfer.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nanotransfer compare?

A PDF of Nanotransfer and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nanotransfer soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Nanotransfer

Nanotransfer is a biotechnology startup based in Argentina, founded in 2021. The company's slogan "Developing the next generation delivery system for gene therapies" encapsulates its goal to revolutionize gene therapies through the development of an innovative gene delivery system. In December 2021, Nanotransfer secured a significant $200.00K Pre Seed Round investment from GRIDX, demonstrating notable interest and support from investors in the biotechnology and healthcare industries. With a promising focus on cutting-edge gene delivery technology, Nanotransfer has potential to make a substantial impact in the field of gene therapies.

Business keywords: Gene therapies, Delivery system, Nanotransfer, Gene delivery system, Healthcare innovation, Medical technology, Genetic engineering, Biopharmaceuticals, Life sciences, Innovative healthcare solutions

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $200.00K 1
GRIDX
25 Dec 2021

Nanotransfer Alternatives & Competitors

View All Alternatives
Nanotransfer vs
Nephrogen
Nephrogen United States

Curative gene therapies for kidney diseases

6 employees
Biotechnology, Health Care
Nanotransfer vs

Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines.

Private Equity
74 employees
Biotechnology, Health Care
Nanotransfer vs

Delivering the next generation gene therapies

Series A
19 employees
Biotechnology, Health Care

FAQ About Nanotransfer

Developing the next generation delivery system for gene therapies
Nanotransfer was founded in 2021.
Nanotransfer is headquartered in Cordoba, Argentina.
Nanotransfer operates in Biotechnology and Health Care. Its work centres on Gene therapies, Delivery system, Nanotransfer and Gene delivery system.
Nanotransfer has approximately 6 employees.
Nanotransfer has completed 1 funding round, raising a total of $200.00K. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Nanotransfer include Nephrogen, Kelonia Therapeutics, AAVantgarde Bio, Affinia Therapeutics, 3T Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nanotransfer and Nephrogen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nanotransfer, https://bouncewatch.com/company/nanotransfer, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes